|
|
| September 29, 2006: Embolic Protection and Thrombectomy: If Yes, When, Who, and How |
This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* The Challenge of Vein Graft Intervention: Progress but No Solution
* Slide 12
* Case Presentation
* Case Presentation
* Case Presentation
* Questions
* Saphenous Vein Graft Disease (SVGD)
* Saphenous Vein Graft (SVG) Disease
* Natural History of SVG
* Saphenous Vein Graft (SVG) Disease
The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.
The guest faculty, James Hermiller, MD, has indicated that he receives research/grant
support from Cordis/Johnson & Johnson, Medtronic, Boston Scientific, and Guidant. In
addition, he is a consultant for Boston Scientific, Guidant, and Abbott.
The fellow, Ing Hann Lim, MD, has indicated that she has nothing to disclose.
|
| |